==== Front
Jpn J Radiol
Jpn J Radiol
Japanese Journal of Radiology
1867-1071
1867-108X
Springer Nature Singapore Singapore

36752955
1397
10.1007/s11604-023-01397-z
Original Article
Predicting the pathological invasiveness of early lung adenocarcinoma prior to surgery using Deauville criteria: reliability and validity
Nishimori Miki miki-nishimori@kochi-u.ac.jp

1
Iwasa Hitomi 1
Nakaji Kosuke 1
Nitta Noriko 1
Miyatake Kana 1
Yoshimatsu Rika 1
Yamanishi Tomoaki 1
Matsumoto Tomohiro 1
Kato Mahiru 2
Hayashi Naoya 3
Toi Makoto 4
Tamura Masaya 5
Yamagami Takuji 1
1 grid.278276.e 0000 0001 0659 9825 Department of Diagnostic and Interventional Radiology, Kochi Medical School, Kochi University, Kohasu, Oko-Cho, Nankoku, Kochi 783-8505 Japan
2 grid.278276.e 0000 0001 0659 9825 Center for Innovative and Translational Medicine, Kochi Medical School, Kochi University, Kohasu, Oko-Cho, Nankoku, Kochi 783-8505 Japan
3 grid.278276.e 0000 0001 0659 9825 Division of Radiology, Department of Medical Technology, Kochi Medical School, Kochi University, Kohasu, Oko-Cho, Nankoku, Kochi 783-8505 Japan
4 grid.278276.e 0000 0001 0659 9825 Department of Diagnostic Pathology, Kochi Medical School, Kochi University, Kohasu, Oko-Cho, Nankoku, Kochi 783-8505 Japan
5 grid.278276.e 0000 0001 0659 9825 Department of Thoracic Surgery, Kochi Medical School, Kochi University, Kohasu, Oko-Cho, Nankoku, Kochi 783-8505 Japan
8 2 2023
8 2 2023
2023
41 7 768776
11 11 2022
23 1 2023
© The Author(s) 2023
https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Purpose

This retrospective study aimed to investigate the validity and reliability of FDG-PET/CT visual assessment using Deauville criteria to predict pathological invasiveness of early lung adenocarcinoma prior to surgery.

Materials and methods

Between April 2020 and January 2022, 51 patients who underwent surgery for pathological stage 0/I lung adenocarcinoma were enrolled. The pulmonary lesions were divided into two groups according to pathological invasiveness: less invasive (including adenocarcinoma in situ and minimally invasive adenocarcinoma and invasive adenocarcinoma. We compared CT size (total and solid size), SUVmax, and Deauville score between the two groups. Furthermore, we investigated inter-rater and intra-rater agreements regarding the Deauville score. Receiver operating characteristic (ROC) curve analysis was performed to identify the diagnostic performance of each method.

Results

Based on pathologic diagnoses, 51 lesions in the 51 patients were divided into 6 less invasive and 45 invasive adenocarcinoma lesions. According to quadratic-weighted Kappa statistics, inter-rater (k = 0.93) and intra-rater (k = 0.97) agreements among all five components of the Deauville score indicated high agreement. There was a statistically significant difference in CT solid size, SUVmax, and Deauville score between the two groups. There were no significant differences between CT solid size and FDG-PET/CT assessments (AUC = 0.93 for Deauville score and SUVmax, AUC = 0.84 for CT solid size).

Conclusion

FDG-PET/CT visual assessment using the Deauville score could assist in deciding upon minimally invasive surgery for early lung adenocarcinoma.

Keywords

Deauville criteria
Lung adenocarcinoma
FDG-PET/CT
issue-copyright-statement© Japan Radiological Society 2023
==== Body
pmcIntroduction

Lung cancer is the leading cause of cancer-related mortality globally, and lung adenocarcinoma is the most frequent histologic subtype [1]. The conventional surgical procedure for lung adenocarcinoma is lobotomy with systematic mediastinal lymphadenectomy. However, in patients with adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) prognosis for survival is good after surgical resection, and recurrence and lymph node metastasis in these patients are rare [2–4]. Therefore, Zhang et al. reported that sublobar resection without lymph node dissection might be the preferred surgical procedure for patients with AIS/MIA [5]. Results of pathology, however, cannot be obtained before surgery. For patients with early lung adenocarcinoma forecasting pathological invasiveness before surgery would be beneficial.

Fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is an important imaging modality for the diagnosis and staging of malignancies [6, 7]. The maximum standardized uptake value (SUVmax) is a good preoperative predictor of the invasiveness of pulmonary adenocarcinoma, similar to findings of CT [8, 9]. However, to our knowledge, no study has focused on the correlation between the visual assessment of FDG-PET/CT findings using Deauville criteria and pathological invasiveness of early lung adenocarcinoma.

This retrospective study aimed to investigate the validity and reliability of the Deauville score to predict pathological invasiveness in patients with early lung adenocarcinoma.

Materials and methods

This research was approved by the Ethical Review Board of our institution. Because this was a retrospective study, the requirement of informed consent by participants was waived. Patients’ records and information were anonymized and de-identified before analysis.

Patients

Study participants had pathological 0/I stage lung adenocarcinoma, had undergone surgery at our Department of Thoracic Surgery, and had preoperative FDG-PET/CT within 3 months before surgery between April 2020 and January 2022.

Exclusion criteria were no thin-slice CT data, chemotherapy just before PET/CT and surgery, previous lung cancer surgery, simultaneous lung cancer upon surgical pathological examination and blood sugar ≧ 150 mg/dL.

Atypical adenomatous hyperplasia (AAH) is typically distinguishable from invasive lung adenocarcinoma due to imaging features [10]. Furthermore, the adenocarcinoma variant subtype is considered to be a relatively rare histological subtype. For the relatively common invasive mucinous adenocarcinomas, several imaging characteristics were reported, and mucinous MIA/AIS are extremely rare [11, 12]. Thus, we excluded those subtypes, such as AAH and adenocarcinoma variant subtype, from the study.

PET/CT Scanning

After fasting for at least 6 h and receiving an intravenous injection of FDG (3.5 MBq/kg), all patients relaxed for about 60 min. Using a PET/CT scanner (Discovery MI, GE Healthcare, Waukesha, WI, USA) with a 64-slice CT component, images from the head to the upper thigh were obtained in the three-dimensional mode for 2 min at each bed position with the patient in a supine position. Non-contrast-enhanced CT images were acquired in the helical mode. A Bayesian penalized likelihood (BPL) reconstruction approach was used to reconstruct the obtained data (Q. clear; GE Healthcare). A β value of 400 was applied to the BPL algorithm. Respiratory gating was performed using a data-driven gating algorithm from GE Healthcare [13]. All patients were scanned with their arms by their sides. All images obtained by CT, PET, and PET/CT were examined.

Evaluation of FDG-PET/CT

PET/CT was evaluated by the imaging analysis software SAI viewer® (Fuji Medical Systems, Tokyo, Japan). In the semiquantitative analysis, the three-dimensional volume of interest to sufficiently cover the primary lesion was set on a PET/CT image, and the SUVmax was automatically measured. The SUVmax is the maximum value of a volume of interest.

For the visual analysis, FDG accumulation was evaluated based on the following Deauville five-point scale: [14]. 1, no FDG uptake above the background; 2, FDG uptake ≤ than that of the mediastinum; 3, FDG uptake > than that of the mediastinum but ≤ than that of the liver; 4, FDG uptake moderately higher than that of liver; and 5, FDG uptake markedly stronger than that of liver.

Thin-slice computed tomography

Using thin-slice CT (<slice thickness 2 mm) and based on lung window manifestations, the ground glass nodule (GGN) component was defined as an area of hazy increased opacity of the lung with preservation of bronchial and vascular margins, whereas the solid component was defined as a patch completely obscuring the underlying lung parenchyma. Total size of the ground glass and/or solid components was expressed by the single largest dimension measured utilizing thin sections and multiplanar reconstructions on CT.

Pathological evaluations

Surgically resected tissues were fixed in 10% neutral buffered formalin, sectioned into 4-μm thick slices, and stained with hematoxylin and eosin. Pathological classifications were according to the criteria of the 2011 IASLC/ATS/ERS classification and the 8th edition UICC-TNM classification [15, 16]. Histological grade was classified into three categories: Grade 1 (adenocarcinoma in situ, minimally invasive carcinoma, and lepidic predominant subtype of invasive adenocarcinoma), Grade 2 (acinar and papillary), and Grade 3 (solid and micropapillary). A pathologist with more than 10 years of diagnostic expertise performed the pathological analysis.

Investigated parameters

Patients were divided into two groups according to pathological invasiveness: less invasive (including AIS and MIA) and invasive adenocarcinoma groups.

We assessed (1) the size of total and solid areas from thin-slice CT imaging and (2) the SUVmax and Deauville score from FDG-PET/CT imaging and after the assessment classified the results as less invasive or invasive adenocarcinoma.

To assess inter-rater reliability, one radiologist with 9 years’ experience with PET (rater 1) and a medical student in her second year (rater 2) separately assessed the Deauville scores. Rater 2 had no prior specific radiological knowledge or practical experience in FDG-PET/CT image evaluation. Instruction of Rater 2 took place in less than two hours through use of a publication regarding the Deauville score [14, 17] and by instructions from rater 1. Furthermore, to assess intra-rater reliability, rater 1 re-examined the same PET imaging 3 months later blinded to the original scores.

Statistical analysis

Statistical analysis was performed using the R software (version 4.13, http://www.r-project.org). Descriptive data were expressed as the median (range). All continuous and ordinal variables were computed using the Wilcoxon-Mann–Whitney Test (‘coin’ package). Spearman's rank correlation coefficients were used to evaluate the relationships between SUVmax and the Deauville score (‘stats’ package). For visual assessment, quadratic-weighted Kappa statistics (‘irr’ package) were used to quantify inter-rater and intra-rater reliability. Receiver operating characteristic (ROC) curve analysis was performed to identify the diagnostic performance of each method (‘pROC’ package). A p value of < 0.05 indicated a statistically significant difference.

Results

Clinical characteristics of lung adenocarcinoma

Fifty-one patients who had undergone complete resection for pulmonary adenocarcinoma were study participants. Lobectomy was performed for 36 lesions and a limited resection for 15 lesions. Table 1 summarizes patients’ characteristics. According to the pathologic diagnosis, of the 51 pulmonary nodules 6 were classified as less invasive (2 AIS and 4 MIA) and 45 as invasive adenocarcinoma. The predominant subtype diagnosis was available for all those in the invasive adenocarcinoma group. Figures 1 and 2 show typical PET/CT images from the less invasive and invasive adenocarcinoma groups, respectively.Table 1 Clinical characterises of study patients

Characteristics	Tumor	
Less invasive (n=6)	Invasive (n=45)	
Age (years)	
 Median	67	76	
 Range	46–78	56–86	
Sex	
 Men	1	20	
 Women	5	25	
Smoking history	
 Yes	2	24	
 No	4	21	
Pathological T stage	
 Tis	2	0	
 T1mi	4	0	
 T1a	0	6	
 T1b	0	19	
 T1c	0	12	
 T2a	0	8	
Histological subtype	
 Adenocarcinoma in situ	2	0	
  Minimally invasive adenocarcinoma	4	0	
 Lepidic predominant	0	3	
 Papillary predominant	0	32	
 Acinar predominant	0	6	
 Solid predominant	0	4	

Fig. 1 FDG-PET/CT and pathological images of a patient with minimally invasive adenocarcinoma (MIA) of the lung. a CT of a 46-year-old woman with a part-solid nodule in the lower lobe of the left lung. Total tumor size was 2.0 cm and solid size was 1.3 cm. (b, c) Axial and a maximum intensity projection image on FDG-PET/CT shows that FDG uptake was increased slightly; the corresponding SUVmax and Deauville score were 1.32 and 2, respectively. (d, e) Histological subtype was an MIA. The pathological total tumor size was 2.0 cm, and the invasive size was 0.4 cm

Fig. 2 FDG-PET-CT and pathological images of a patient with invasive lung adenocarcinoma. a CT shows that in an 82-year-old woman with a solid nodule in the lower lobe of the left lung that the solid size was 1.6 cm. b, c Axial and a maximum intensity projection image on FDG-PET/CT shows that FDG uptake was increased strongly and the corresponding SUVmax and Deauville score were 6.51 and 5, respectively. (d, e) Histological subtype was papillary predominant lung adenocarcinoma. The pathological total and invasive size were both 1.2 cm

SUVmax, total lesion size on CT, and solid size on CT of lung adenocarcinoma

The median SUVmax, total size on CT, and solid size on CT for the 51 pulmonary adenocarcinomas were 3.75 (range, 0.76–16.50), 2.4 cm (range, 0.8–4.7 cm), and 1.9 cm (range, 0–4.7 cm), respectively. The median SUVmax values for AIS, MIA, and invasive adenocarcinoma were 1.11 (range, 0.87–1.35), 1.38 (range, 0.89–3.75), and 4.97 (range, 0.76–16.50), respectively. Median total sizes on CT of AIS, MIA, and invasive adenocarcinoma were 1.4 cm (range, 1.3–1.5), 2.5 cm (range, 1–2.7), and 2.4 cm (range, 0.8–4.7), respectively. The median solid sizes for AIS, MIA, and invasive adenocarcinoma on CT were 0.25 cm (range, 0–0.5), 1.3 cm (range, 0.3–2.6), and 1.95 cm (range, 0.7–4.7), respectively.

Deauville scores for lung adenocarcinoma

Of the six patients with less invasive adenocarcinoma the Deauville score was 1 in three patients and 2 in three patients. As to the 45 invasive adenocarcinomas the Deauville score was 1 in 1 patient, 2 in 10 patients, 3 in 6 patients, 4 in 6 patients, and 5 in 22 patients. Deauville score 1 or 2 for invasive adenocarcinoma was classified as pathological grade 1 in 1/3 patients (33%) and pathological grade 2 in 10/38 patients (26%). No invasive adenocarcinoma with a Deauville score of 1 or 2 was classified as pathological grade 3 (0%, 0/4 patients).

Correlation of SUVmax and Deauville scores

The median SUVmax was 0.88 (range, 0.76–1.35) for Deauville score 1, 1.75 (range, 1.14–2.44) for Deauville score 2, 3.38 (range, 2.48–3.71) for Deauville score 3, 4.02 (range, 2.8–8.54) for Deauville score 4 and 9.26 (range, 4.62–16.5) for Deauville score 5. A high correlation coefficient (r = 0.93) was found between the SUVmax and the Deauville score.

Inter-rater and intra-rater agreements with Deauville score

Tables 2 and 3 show inter-rater and intra-rater agreements on Deauville scores. According to quadratic-weighted Kappa statistics, the inter-rater κ-value (rater 1–1 [first-time examination] vs. rater 2) of κ = 0.93 and intra-rater (rater 1–1 vs. rater 1–2 [second-time examination]) k-value of κ = 0.97 for Deauville scores indicated high agreement.Table 2 Inter-rater agreement for Deauville scores

	Rater 1-1	
Score 1	Score 2	Score 3	Score 4	Score 5	Total	
Rater 2	Score 1	4	5	0	0	0	9	
	Score 2	0	8	3	1	0	12	
	Score 3	0	0	3	3	0	6	
	Score 4	0	0	0	1	2	3	
	Score 5	0	0	0	1	20	21	
	Total	4	13	6	6	22	51	

Table 3 Intra-rater agreement for Deauville scores

	Rater 1-1	
Score 1	Score 2	Score 3	Score 4	Score 5	Total	
Rater 1-2	Score 1	3	0	0	0	0	3	
	Score 2	1	13	1	0	0	15	
	Score 3	0	0	5	2	0	7	
	Score 4	0	0	0	3	1	4	
	Score 5	0	0	0	1	21	22	
	Total	4	13	6	6	22	51	

Differentiation of lung invasiveness using image-based analysis

Table 4 summarizes the differentiation of lung invasiveness using image-based analysis. There was a significant difference in CT solid size (p < 0.01), Deauville score for both rater 1 (p < 0.01) and rater 2 (p < 0.01), and SUVmax (p < 0.01) between the less invasive and invasive adenocarcinoma groups. On the other hand, there was no significant difference in CT total size (p = 0.21) between the two groups.Table 4 Differentiation of lung invasiveness using Image-based analysis

Tumor	
	Less invasive (n= 6)	Invasive (n= 6)	p value	
CT : Total size (cm)	1.75(1–2.7)	2.4(0.8–4.7)	0.21	
CT : Solid size (cm)	0.65(0–2.5)	2(0.7–4.7)	<0.01*	
PET : Deauville score of rater 1	1.5(1–2)	4(1–5)	<0.01*	
PET : Deauville score of rater 2	1(1–2)	4(1–5)	<0.01*	
PET : SUVmax	1.34(0.87–2.39)	4.73(0.76–16.5)	<0.01*	
SUVmax maximum standardized uptake value

“Deauville score of rater 1” indicates the first time rater 1 performed the examination

*p value < 0.05 indicates a statistically significant difference

ROC

Table 5 summarizes the AUCs from ROC analysis of the Deauville score, SUVmax, and CT solid size. Figure 3 depicts ROC curves for each method. ROCs for the Deauville score (AUC = 0.93 for both rater 1 and rater 2) and SUVmax (AUC = 0.93) showed equivalent accuracy. The AUC for CT solid size was slightly lower (AUC = 0.84) than visual and semiquantitative FDG-PET/CT assessments. However, there were no significant differences between CT solid size and FDG-PET/CT assessments (CT solid size vs. Deauville score by rater 1, p = 0.41; Deauville score by rater 2, p = 0.49; and SUVmax, p = 0.46).Table 5 Receiver operating characteristic curve analysis

	ROC	
AUC	95%CI	Cut off value	Sensitivity (%)	Specificity (%)	
Deauville score: rater1	0.93	0.86–1	2.5	75.60	100.0	
Deauville score: rater2	0.93	0.86–1	1.5	91.10	83.3	
SUVmax	0.93	0.85–1	1.45	95.60	83.30	
CT solid size	0.84	0.60–1	1.35	77.80	83.30	
SUVmax maximum standardized uptake value

“Deauville score: rater 1” indicates the first time rater 1 performed the examination

Fig. 3 Receiver operating characteristic (ROC) curve for the Deauville score (rater 1 at the first examination and rater 2), SUVmax, and CT solid size

Discussion

Because invasive and less invasive adenocarcinoma (AIS and MIA) can potentially be treated differently, it is crucial for surgeons to preoperatively estimate a tumor's invasiveness to determine the appropriate treatment. However, pathologic findings cannot be obtained preoperatively. Therefore, prediction of the presence of a less invasive adenocarcinoma through preoperative imaging is important for clinical decision-making when treating patients with early-stage lung adenocarcinoma. It has been reported that total size and solid component size that can be derived from CT imaging can be used to differentiate between invasive and less invasive lung adenocarcinoma [9, 18]. However, because CT imaging provides only a morphological evaluation, the potential for differentiation of invasiveness by size alone remains debatable. For a more accurate preoperative diagnosis, we must incorporate different types of imaging modalities.

In the present study, we clarified that the Deauville score was an aid in predicting pathological invasiveness of early lung adenocarcinoma. According to rater 1–1, all less invasive adenocarcinomas had a Deauville score of 1 or 2. No patient with pathological Grade 3 invasive adenocarcinoma was given a Deauville score of 1 or 2. Previously, Kagimoto et al. reported that the Deauville score was useful in predicting not only lymph node metastasis but also lymphatic, vascular, or visceral pleural invasion of early-stage lung adenocarcinoma [17]. Our study demonstrated that the Deauville score can also be applied to predict less invasive lung adenocarcinomas, including AIS and MIA. This indicates that the Deauville score has the potential to reflect the degree of pathological malignancy of a tumor. FDG-PET/CT is an important imaging tool for evaluating primary lung cancer prior to surgery and provides a number of semiquantitative parameters, with SUVmax being the most commonly used [19, 20]. It was noted that the preoperative evaluation of SUVmax could help to distinguish pathological invasiveness of lung adenocarcinoma [8]. However, access is needed to a workstation suitable for PET/CT imaging to assess SUVmax. Also, SUVmax is variable among studies and institutions according to differences in imaging protocols, equipment, etc. so it cannot be used as inclusion criteria. Assessment using Deauville criteria based on FDG-PET/CT findings can eliminate those disadvantages of SUVmax [14]. Our present results showed a high correlation coefficient between SUVmax and Deauville scores. The AUCs of Deauville scores were comparable to SUVmax. Moreover, each Deauville score covered a large area expressed as an SUVmax. Using Deauville criteria, we can assess the degree of FDG uptake succinctly and efficiently rather than using SUVmax.

We found no significant differences between the AUCs of the Deauville score and CT solid size. That the preoperative solid size on CT can help differentiate AIS and MIA from invasive adenocarcinomas was reported [21]. Our study indicated that Deauville scores achieved good diagnosability, similar to CT solid size. Furthermore, there were no significant differences between CT solid size and FDG-PET/CT assessments but the Deauville score and SUVmax had slightly higher AUCs in our study than CT solid size for predicting the invasiveness of lung adenocarcinoma. The AUC of CT solid size (0.84) was a little lower than the lower limit of the 95% confidence interval (CI) for the Deauville score (95%CI 0.86–1) and SUVmax (95%CI 0.85–1). Solid size measurement involves issues of inconsistency with the invasive size determined using pathological specimens [22]. The solid size shown on thin-section CT may be larger than that of the actual invasive component, because the solid components shown on CT contain cancer cells as well as alveolar collapse, fibrosis, etc. Although PET/CT has lower spatial resolution than CT, the degree of FDG accumulation more accurately reflects tumor invasiveness [23]. Therefore, using the Deauville score based on FDG-PET/CT is an attempt to resolve these issues related to CT. However, due to the possibility of sample bias and poor statistical power the consequences of using these results are difficult to determine. Further validation is needed to clarify differences in the diagnostic value between the Deauville score and CT findings. The combination of FDG-PET/CT and CT is widely used for imaging protocols before surgery. At present, thoracic surgeons mainly use CT imaging to determine indications for limited resection of early lung adenocarcinoma. The results of the present study indicate that when deciding upon the operative method, the Deauville score should be considered.

In a recent study, Choi et al. reported a high degree of interobserver agreement for the measurement of solid components of lung adenocarcinoma between a radiologist and pulmonologists and between residents versus fellows [24]. Furthermore, excellent agreement between raters for Hodgkin lymphoma was reported for the Deauville score [14].To our knowledge, the present study is the first to examine whether the criteria for the Deauville score are robust enough to permit good reliability for assessing early lung adenocarcinoma. The results showed that it was sufficiently robust for that purpose. Furthermore, it was notable that after a short period of instruction using a published manuscript describing the Deauville score, a medical student without PET experience could use the Deauville score. Deauville score is a simple and dependable visual measurement for evaluating the pathological invasiveness of lung adenocarcinoma on PET. This method simply requires the use of the eyes and some fundamental knowledge of FDG-PET/CT. We anticipate that the Deauville score may be valuable for thoracic surgeons and other experts who do not specialize in PET diagnostics, not only radiologists.

Our study had some limitations. First, this was a retrospective study and involved data from a single institution. As a result, there is a possibility of bias. Second, the sample size was relatively small, especially the number of less invasive adenocarcinoma cases. Therefore, further studies with a larger patient population are required to confirm our results. However, this is the first report to evaluate the reliability and validity of the Deauville score for predicting pathological invasiveness of early lung carcinoma. Based on the present results, it appears that the Deauville score for lung cancer will be a critical consideration by surgeons as part of preoperative examinations for lung cancer.

In conclusion, with FDG-PET/CT a visual assessment using the Deauville score correlated with pathological invasiveness of early lung adenocarcinoma. The Deauville score is a simple and dependable visual measure that might assist thoracic surgeons in planning minimally invasive surgery for early lung adenocarcinoma.

Declarations

Conflict of interest

The authors have no conflicts of interest

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Rami-Porta R Bolejack V Crowley J Ball D Kim J Lyons G The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer J Thorac Oncol 2015 10 990 1003 10.1097/JTO.0000000000000559 26134221
2. Jiang L Yin W Peng G Wang W Zhang J Liu Y Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis J Thorac Dis 2015 7 2003 2009 26716039
3. Kadota K Villena-Vargas J Yoshizawa A Motoi N Sima CS Riely GJ Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease Am J Surg Pathol 2014 38 448 460 10.1097/PAS.0000000000000134 24472852
4. Yotsukura M Asamura H Motoi N Kashima J Yoshida Y Nakagawa K Long-Term prognosis of patients with resected adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung J Thorac Oncol 2021 16 1312 1320 10.1016/j.jtho.2021.04.007 33915249
5. Zhang Y Ma X Shen X Wang S Li Y Hu H Surgery for pre- and minimally invasive lung adenocarcinoma J Thorac Cardiovasc Surg 2022 163 456 464 10.1016/j.jtcvs.2020.11.151 33485660
6. Bar-Shalom R Yefremov N Guralnik L Gaitini D Frenkel A Kuten A Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management J Nucl Med 2003 44 1200 1209 12902408
7. Tsutani Y Miyata Y Nakayama H Okumura S Adachi S Yoshimura M Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection J Thorac Cardiovasc Surg 2012 144 1365 1371 10.1016/j.jtcvs.2012.07.012 22883546
8. Fu L Alam MS Ren Y Guan W Wu H Wang Q Utility of maximum standard uptake value as a predictor for differentiating the invasiveness of T1 stage pulmonary adenocarcinoma Clin Lung Cancer 2018 19 221 229 10.1016/j.cllc.2017.11.009 29275041
9. Kudo Y Matsubayashi J Saji H Akata S Shimada Y Kato Y Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients Lung Cancer 2015 90 47 54 10.1016/j.lungcan.2015.07.007 26259875
10. Travis WD Asamura H Bankier AA Beasley MB Detterbeck F Flieder DB The IASLC lung cancer staging project proposals for coding t categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the tnm classification of lung cancer J Thorac Oncol 2016 11 8 1204 1223 10.1016/j.jtho.2016.03.025 27107787
11. Zhang X Qiao W Kang Z Pan C Chen Y Li K CT Features of stage IA invasive mucinous adenocarcinoma of the lung and establishment of a prediction model Int J Gen Med 2022 15 5455 5463 10.2147/IJGM.S368344 35692354
12. Miyata N Endo M Nakajima T Kojima H Maniwa T Takahashi S High-resolution computed tomography findings of early mucinous adenocarcinomas and their pathologic characteristics in 22 surgically resected cases Eur J Radiol 2015 84 993 997 10.1016/j.ejrad.2015.01.014 25681135
13. Walker MD Morgan AJ Bradley KM McGowan DR Data-driven respiratory gating outperforms device-based gating for clinical (18)F-FDG PET/CT J Nucl Med 2020 61 1678 1683 10.2967/jnumed.120.242248 32245898
14. Barrington SF Qian W Somer EJ Franceschetto A Bagni B Brun E Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma Eur J Nucl Med Mol Imaging 2010 37 1824 1833 10.1007/s00259-010-1490-5 20505930
15. Travis WD Brambilla E Noguchi M Nicholson AG Geisinger KR Yatabe Y International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma J Thorac Oncol 2011 6 244 285 10.1097/JTO.0b013e318206a221 21252716
16. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, 8th edition; 2017.
17. Kagimoto A Tsutani Y Izaki Y Handa Y Mimae T Miyata Y Prediction of lymph node metastasis using semiquantitative evaluation of PET for lung adenocarcinoma Ann Thorac Surg 2020 110 1036 1042 10.1016/j.athoracsur.2020.03.032 32302663
18. Qiu ZX Cheng Y Liu D Wang WY Wu X Wu WL Clinical, pathological, and radiological characteristics of solitary ground-glass opacity lung nodules on high-resolution computed tomography Ther Clin Risk Manag 2016 12 1445 1453 10.2147/TCRM.S110363 27703366
19. Sun XY Chen TX Chang C Teng HH Xie C Ruan MM SUVmax of (18)FDG PET/CT predicts histological grade of lung adenocarcinoma Acad Radiol 2021 28 49 57 10.1016/j.acra.2020.01.030 32113879
20. Kadota K Colovos C Suzuki K Rizk NP Dunphy MP Zabor EC FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma Ann Surg Oncol 2012 19 3598 3605 10.1245/s10434-012-2414-3 22644511
21. Cohen JG Reymond E Lederlin M Medici M Lantuejoul S Laurent F Differentiating pre- and minimally invasive from invasive adenocarcinoma using CT-features in persistent pulmonary part-solid nodules in caucasian patients Eur J Radiol 2015 84 738 744 10.1016/j.ejrad.2014.12.031 25623825
22. Yanagawa M Kusumoto M Johkoh T Noguchi M Minami Y Sakai F Radiologic-pathologic correlation of solid portions on thin-section CT images in lung adenocarcinoma: a multicenter study Clin Lung Cancer 2018 19 e303 e312 10.1016/j.cllc.2017.12.005 29307591
23. Iwano S Ito S Kamiya S Ito R Kato K Naganawa S Utility of metabolic parameters on FDG PET/CT in the classification of early-stage lung adenocarcinoma: prediction of pathological invasive size Clin Nucl Med 2019 44 560 565 10.1097/RLU.0000000000002591 31021916
24. Choi Y Kim SH Kim KH Choi Y Park SG Sohn I Clinical T category for lung cancer staging: a pragmatic approach for real-world practice Thorac Cancer 2020 11 3555 3565 10.1111/1759-7714.13701 33075213